Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis

Vipul Jairath, Russell D. Cohen, Edward V. Loftus, Ninfa Candela, Karen Lasch, Bob G. Schultz

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis'. Together they form a unique fingerprint.

Medicine & Life Sciences